Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“Survival rates vary significantly by stage of the disease. Those with serious cancers (multiple myeloma) who are in stage 1, for example, may have better survival rates than those with stage 2 or 3 cancer…”
On the sales page for the MM Cancer Coaching Program I make the statement that the FDA approved standard-of-care therapy plan for multiple myeloma is effective for stage 2 or 3 MM patients who are willing to undergo aggressive chemotherapy to achieve an average survival of 5-7 years.
I don’t mean to sound snarky when I make that statement. I didn’t pay attention to the published studies when I was diagnosed with MM so I can see how other people wouldn’t pay attention to the averages either.
Let me be clear. If you are the average MM patient (65-75 years of age, stage 2 or 3/advanced MM), the FDA standard-of-care therapy plan of induction chemo (RVD or similar), an autologous stem cell transplant followed by maintenance therapy:
To be fair, stage 2, 3 MM is fairly advanced MM. Conventional oncology has worked hard to learn how to stabilize the MM patient s with advanced MM. Aggressive chemo is required to put the newly diagnosed MM patient into remission.
But it is essential for the newly diagnosed MM patient to understand that that stabilization comes at a cost.
I’ve linked and excerpted the article below to highlight three important issues for the newly diagnosed MM patient.
A patient’s albumin and beta 2 micro globulin levels can tell the patient a lot about how he/she will survive, how much chemotherapy he/she should have.
Please determine your stage at diagnosis. You can study your diagnostic info to do this or you can send me your diagnostic info and I can tell you your lab values- especially your monoclonal proteins, B2M, albumin, etc.
Your stage, age, current health, etc. will point you toward your therapy plan. You may or may not need the standard-of-care, one size fits all therapies for multiple myeloma.
As the saying goes, knowledge is power!
Let me know if you have any questions. Thanks for your time and attention.
Survival rates vary significantly by stage of the disease. Those with serious cancers who are in stage 1, for example, may have better survival rates than those with stage 2 or 3 cancer…
The survival rates of multiple myeloma are estimated based on epidemiologic data collected by the National Cancer Institute’s SEER program, and the stages they use for multiple myeloma are different from the ones they use for solid tumor cancer.2
Under the SEER program, multiple myeloma is classified by the number of tumors present, and are described as localized (one tumor), distant (many tumors throughout the body), and regional. Since multiple myeloma does not travel to the lymph nodes, the regional stage does not apply.
|Five-year Survival Rate of Multiple Myeloma by Stage|
|Stage||Percent of Cases by Stage||Five-Year Survival Rate|
|All stages combined||100%||52%|
These survival rates don’t take personal risk factors into account. For example, if a person with distant multiple myeloma takes care of their health in every aspect, their likelihood of survival could be better than someone who has the same condition but does not lead a healthy lifestyle…
The stages of multiple myeloma as defined by the International Staging System are:3
Several clinical and laboratory findings considered prognostic indicators can help determine how fast the tumor is growing,